unknown
Stage
About
Gritstone Bio develops immunotherapies that use multi-specific antibodies to target tumor cells and stimulate durable immune responses, focusing on cancers such as lung, gastric, esophageal, head & neck, and cervical cancers.
Explore Gritstone Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.